Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...

Researchers identified bemnifosbuvir as a potential treatment for hepatitis E, finding that it inhibited viral replication in cell models. Animal studies showed efficacy and reduced liver inflammation ...

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...

A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since retired, but a public health educator to the end, I’d like to remind ...

For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen.

These findings, alongside the linked systematic review and meta-analysis of antiviral treatment efficacy, supported the 2024 WHO guidelines expansion of treatment criteria to include individuals with ...

With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led Hepatitis B and HIV Cure Consortium has received a $24 millio ...

For people living with human immunodeficiency virus (HIV), antiretroviral therapy prevents HIV-infected immune cells from replicating the virus to protect against illness and transmission. Inactive ...

Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...